Annals

Eurofins Viracor is a specialized diagnostic laboratory within the Eurofins network, offering advanced testing solutions in infectious diseases, immunology, and transplant diagnostics. Serving healthcare providers, researchers, and pharmaceutical companies, the lab delivers fast, accurate results to support critical decision-making and scientific advancement. With a U.S.-based facility and global reach, Eurofins Viracor combines cutting-edge technology, expert staff, and a commitment to quality to improve patient outcomes and drive innovation in diagnostics.

We're advancing the fight against invasive fungal infections with quantitative PCR (qPCR), a powerful diagnostic tool that delivers rapid, sensitive, and specific detection of Blastomyces, Histoplasma, Coccidioides, and Cryptococcus species. Traditional methods like culture and serology often delay diagnosis, but qPCR enables us to detect fungal DNA directly from BAL, CSF, and sputum within hours...

April is National Donate Life Month, a time to honor the generosity of donors and the strength of transplant recipients. At Eurofins Viracor, we recognize this meaningful month by highlighting our commitment to supporting every step of the transplant journey...

Chagas disease, caused by Trypanosoma cruzi (T. cruzi), is an emerging global health concern, particularly for immunocompromised individuals like solid organ transplant (SOT) recipients, who are at high risk for severe complications from reactivation. Traditional diagnostic methods, such as serology and microscopy...

Respiratory illnesses like RSV, flu, and other viruses can pose serious risks, especially for young children, older adults, and those with weakened immune systems. Since symptoms often overlap, accurate testing is essential for proper diagnosis and treatment. Eurofins Viracor offers advanced laboratory testing to help healthcare providers...

The latest article in the Transplantation journal examines how immune monitoring assays can predict outcomes for transplant patients by identifying transplant rejection and personalizing immunosuppressive therapies. The study highlights various assay types and their potential to improve clinical decision-making and patient care...

This interactive e-book presents a synopsis of our operations, services, and, most importantly, our commitment to you and your patients. Viracor delivers accurate results, exceptional turnaround times, and personalized guidance that empowers you to make informed healthcare decisions for your patients...